$700.22
0.780.11%
At close: Nov 13, 4:00 PM EST
$700.00
-0.22-0.03%
After Hours: Nov 13, 6:27 PM EST
Thermo Fisher Scientific Inc
TMONYSE
Thermo Fisher Scientific (TMO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 21, 2026 | $6.68 | $6.40 | 4.37 % |
| Q2 | Jul 23, 2026 | $6.03 | $5.71 | 5.60 % |
| Q1 | Apr 23, 2026 | $5.44 | $5.23 | 4.02 % |
| Q4 | Jan 29, 2026 | $6.57 | $6.44 | 2.02 % |
Quarterly Revenue (Billions)
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 21, 2026 | $12.14B | $11.94B | 1.61 % |
| Q2 | Jul 23, 2026 | $11.99B | $11.70B | 2.54 % |
| Q1 | Apr 23, 2026 | $11.01B | $10.85B | 1.38 % |
| Q4 | Jan 29, 2026 | $12.22B | $11.91B | 2.54 % |
Thermo Fisher Scientific (TMO) last issued guidance on October 21, 2026 for fiscal year 2026. The company guided earnings per share in the range of $25.13 - $25.43, compared to a consensus EPS estimate of $25.14. Thermo Fisher Scientific also guided revenue in the range of $47.7B - $48.2B for the period.
Compared to prior guidance, Thermo Fisher Scientific maintained its EPS outlook from a previous range of $24.93 - $25.33. On the revenue side, the company maintained its revenue forecast from a prior range of $47.4B - $48.1B.
Thermo Fisher Scientific has issued 17 guidance updates between February 1, 2023 and October 21, 2026. During this period, the company raised its outlook 5 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $6.40 | $5.71 | $5.23 | $6.44 |
| Actual | $6.68 | $6.03 | $5.44 | $6.57 |
| Surprise | +4.37% | +5.60% | +4.02% | +2.02% |
| Revenue | ||||
| Estimate | $11.94B | $11.70B | $10.85B | $11.91B |
| Actual | $12.14B | $11.99B | $11.01B | $12.21B |
| Surprise | +1.61% | +2.54% | +1.38% | +2.54% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $7.13 | $6.03 | $6.57 | $7.22 |
| Revenue | ||||
| Consensus | $12.86B | $11.72B | — | — |
